|
| |
Malignant HyperthermiaDownload PDF containing detailed information.
Recent Publications on Malignant Hyperthermia: |  |
Malignant hyperthermia: a pharmacogenetic disorder.
OBJECTIVE: We report the findings of Thallium-201 chloride ((201)TlCl)... | 12th November, 2009
| Department of Pharmacy, Barnes-Jewish Hospital, St. Louis, MO 63110, USA.
| Orthopedics. 2009 Nov;32(11):835. doi: 10.3928/01477447-20090922-18.
DOI Direct Link |
[Mitochondrial myopathies]
The organ most frequently affected in mitochondrial disorders is the... | 6th November, 2009
| Krankenanstalt
| Fortschr Neurol Psychiatr. 2009 Nov;77(11):631-8. Epub 2009 Nov 3.
DOI Direct Link |
A mathematical model to improve on phenotyping for molecular genetic research in malignant hyperthermia.
BACKGROUND: The in-vitro contracture test is the standard test to diagnose... | 6th November, 2009
| aDepartment of Anaesthesia, Division of Operative Critical Care, County
| Pharmacogenet Genomics. 2009 Nov 3.
DOI Direct Link |
The role of CACNA1S in predisposition to malignant hyperthermia.
BACKGROUND: Malignant hyperthermia (MH) is an inherited pharmacogenetic... | 31st October, 2009
| MH Investigation Unit, Academic Unit of Anaesthesia, St James's University
| BMC Med Genet. 2009 Oct 13;10:104.
DOI Direct Link |
Sevoflurane modulation of Ca(2+) regulation in skeletal muscle sarcoplasmic reticulum vesicles from young and mature rabbits.
Introduction: Developmental differences in splice variants of the two key... | 30th October, 2009
| Department of Anesthesiology, Wake Forest University School of Medicine,
| Paediatr Anaesth. 2009 Oct 21.
DOI Direct Link |
→View more research publications. |
Press Releases About Malignant Hyperthermia:
|
 |
| FDA Advisory Committee Recommends Approval of PEGINTRON(R) for the Adjuvant Treatment of Stage III Malignant Melanoma |
5th October, 2009 |
Schering-Plough Corp. |
GAITHERSBURG, Md., Oct. 5, /PRNewswire-FirstCall/ -- Schering-Plough Corp. (NYSE: SGP) announced today that the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC)
|
| JHP Pharmaceuticals Introduces a Dantrium(R) IV (dantrolene sodium for injection), Rapidly Mixing at 20 Seconds |
28th September, 2009 |
JHP Pharmaceuticals, LLC |
-- Easier and faster introduction of diluent into the Dantrium® IV vial
JHP has also introduced two new features in the Dantrium® IV vial; an easy-to-open flip-off vial cap and an easy-to
|
| Reportlinker Adds World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition, The Report |
24th September, 2009 |
Reportlinker |
-- SERMS
The report includes market share by type of cancer and market share by company for each of the three major segments. It also includes statistical information for cancers by type
|
| SCHERING-PLOUGH ANNOUNCES FDA APPROVAL OF SAPHRIS(R) (asenapine): for acute treatment of schizophrenia in adults and manic or mixed episodes of bipolar I disorder with or without psychotic features in adults |
14th August, 2009 |
Schering-Plough |
Schering-Plough Corporation (NYSE: SGP) today announced that the U.S.
Food and Drug Administration (FDA) has approved SAPHRIS(R) (asenapine)
sublingual tablets for acute treatment of schizophrenia
|
| MDOUTLOOK(R) Quick Polls Report on Clinical Integration of Key Oncology Developments Following ASCO 2009 |
24th June, 2009 |
The Arcas Group |
ATLANTA, June 24 /PRNewswire/ -- MDOUTLOOK(R), the innovative oncology intelligence platform, today announced the results from its Quick Poll research, which was launched immediately following this
|
BioPortfolio Ltd. offers e-mail and postal lists for Malignant Hyperthermia scientists - we have details of around 343 individuals working on Malignant Hyperthermia .
This page has been viewed 342 times
Recent Search Terms used to find this page: malignant hyperthermia 2009 | malignant hyperthermia and logo | malignant hyperthermia logo | malignant hyperthermia logo | malignant hyperthermia logo | malignant hyperthermia trials | malignant hyperthermia research trials | malignant hyperthermia clinical trial | preparation of malignant hyperthermia medication | .
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Malignant Hyperthermia across BioPortfolio, or for Malignant Hyperthermia Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|
